or Try an Advanced Search...

    Genetic Diseases Stocks List

    Symbol Grade Name % Change
    ADVM F Adverum Biotechnologies, Inc. -6.81
    INZY F Inozyme Pharma, Inc. -3.58
    BMRN F BioMarin Pharmaceutical Inc. 1.42
    SYBX F Synlogic, Inc. -2.75
    BDTX F Black Diamond Therapeutics, Inc. 0.00
    CODX F Co-Diagnostics, Inc. 1.92
    STOK F Stoke Therapeutics, Inc. -0.35
    LRMR D Larimar Therapeutics, Inc. 0.82
    KRYS C Krystal Biotech, Inc. 2.35
    LUMO B Lumos Pharma, Inc. 0.23
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biotechnology Disease Rare Genetic Disease Biopharmaceutical Cancer Medicine Rare Diseases Rare Genetic Diseases Biology Clinical Medicine Drug Discovery Gene Therapy Inborn Errors Of Metabolism Intellectual Disability Life Sciences Pharmacy Phenylketonuria Pku Achondroplasia Acid

    Related ETFs - A few ETFs which own one or more of the above listed Genetic Diseases stocks.

    Symbol Grade Name Weight
    HELX D Franklin Genomic Advancements ETF 4.9
    PBE D PowerShares Dynamic Biotech & Genome 3.76
    GNOM F Global X Genomics & Biotechnology ETF 3.71
    SBIO C ALPS Medical Breakthroughs ETF 3.51
    XBI D SPDR S&P Biotech ETF 3.43
    View all Genetic Diseases ETFs...
    Compare ETFs
    Compare HELX to SBIO Compare PBE to XBI Compare SBIO to XBI

        Genetic Diseases Stocks Recent News

        Date Stock Title
        Nov 21 BMRN Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 BMRN BioMarin: Challenges Mount, But Sale Rumors Make For A Risky 'Buy' Call
        Nov 21 BMRN Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
        Nov 20 ADVM Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
        Nov 20 STOK Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
        Nov 19 BMRN BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
        Nov 18 ADVM Adverum: Ixo-Vec Could Reduce Treatment Burden For Wet-AMD Patients
        Nov 18 ADVM Adverum Reports Positive Ixo-vec Data for Wet Age-Related Macular Degeneration; Shares Rise Pre-Bell
        Nov 18 ADVM Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
        Nov 18 LRMR Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
        Nov 16 BMRN BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
        Nov 15 ADVM Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements
        Nov 15 SYBX Synlogic Third Quarter 2024 Earnings: US$0.01 loss per share (vs US$2.57 loss in 3Q 2023)
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biotechnology Disease Rare Genetic Disease Biopharmaceutical Cancer Medicine Rare Diseases Rare Genetic Diseases Biology Clinical Medicine Drug Discovery Gene Therapy Inborn Errors Of Metabolism Intellectual Disability Life Sciences Pharmacy Phenylketonuria Pku Achondroplasia Acid
        Genetic Diseases

        Genetic diseases are disorders caused by changes in genes or chromosomes. These changes can be inherited from a parent or acquired during a person's lifetime. Examples of genetic diseases include cystic fibrosis, sickle cell anemia, and Huntington's disease.

        Browse All Tags